natgillin/translations-raw huggingface dataset:
Thalidomid er et kraftigt humant teratogen, der inducerer en høj frekvens af alvorlige og livstruende fødselsdefekter.
Thalidomide is a powerful human teratogen, inducing a high frequency of severe and life- threatening birth defects.
Thalidomid er et kraftigt humant ”teratogen”, dvs. det har en skadelig virkning, der giver alvorlige og livstruende fødselsdefekter hos det ufødte barn.
Thalidomide is a powerful human ‘teratogen’, meaning that it has a harmful effect on the unborn child, causing severe and life-threatening birth defects.
Thalidomid er kendt som et teratogent stof hos mennesker og forårsager svære livstruende fødselsdefekter.
Thalidomide is a known human teratogen that causes severe life- threatening birth defects.
Thalidomid er kendt som et teratogent stof hos mennesker og forårsager svære livstruende fødselsdefekter.
Thalidomide is a known human teratogenic active substance that causes severe life-threatening birth defects.
Thalidomid er til stede i sæd hos mandlige patienter i mængder, der svarer til plasmakoncentrationen.
Thalidomide is present in the semen of male patients at levels similar to plasma concentrations.
Thalidomid forårsager ofte døsighed.
Thalidomide frequently causes somnolence.
Thalidomid har et kiralt center og benyttes klinisk som racemisk blanding af (+)-(R)- og (-)-(S)- thalidomid.
Thalidomide has a chiral centre and is used clinically as a racemate of (+)-(R)- and (-)-(S)- thalidomide.
Thalidomid har sedative egenskaber og kan derfor forøge den sedative virkning af anxiolytika, hypnotika, antipsykotika, H1-antihistaminer, opiumderivater, barbiturater og alkohol.
Thalidomide has sedative properties thus may enhance the sedation induced by anxiolytics, hypnotics, antipsychotics, H1 anti-histamines, opiate derivatives, barbiturates and alcohol.
Thalidomid må aldrig benyttes af kvinder, der er gravide, eller af kvinder, der kan blive gravide, medmindre alle betingelserne i Thalidomide Celgenes Svangerskabsforebyggelsesprogram er opfyldt.
Thalidomide must never be used by women who are pregnant or by women who could become pregnant unless all the conditions of the Thalidomide Celgene Pregnancy Prevention Programme are met.
Thalidomid skal seponeres, hvis der forekommer hududslæt, og behandlingen bør kun genoptages efter passende klinisk evaluering.
Thalidomide should be discontinued if a skin rash occurs and only resumed following appropriate clinical evaluation.
Thalidomid udskilles i sædvæsken.
Thalidomide passes into semen.
Thalidomid udviser immunmodulerende antiinflammatorisk og potentielt antineoplastisk aktivitet.
Thalidomide shows immunomodulatory anti-inflammatory and potential anti-neoplastic activities.
Thalidomid-dosis øges til 100 mg fra uge 3 i cyklus 1, men kun hvis 50 mg tåles, og til 200 mg fra og med cyklus 2, hvis 100 mg tåles.
Thalidomide dose is increased to 100 mg from week 3 of Cycle 1 only if 50 mg is tolerated and to 200 mg from cycle 2 onwards if 100 mg is tolerated.
Thalidomide Celgene 50 mg hård kapsel.
Thalidomide Celgene 50 mg hard capsules
Thalidomide Celgene 50 mg hårde kapsler
Thalidomide Celgene 50 mg hard capsules
Thalidomide Celgene 50 mg hårde kapsler Thalidomid
Thalidomide Celgene 50 mg hard capsules Thalidomide
Thalidomide Celgene 50 mg Thalidomid
Thalidomide Celgene 50 mg Thalidomide
Thalidomide Celgene anvendes til at behandle multipelt myelom (knoglemarvskræft), i kombination med kræftmidlerne melphalan og prednison hos patienter, der ikke tidligere er blevet behandlet for multipelt myelom.
Thalidomide Celgene is used to treat multiple myeloma (a cancer of the bone marrow) in combination with the cancer medicines melphalan and prednisone in patients who have not been treated for multiple myeloma before.
Thalidomide Celgene benyttes sammen med to andre lægemidler, der hedder melphalan og prednison, til behandling af voksne på 65 år og derover med en kræfttype, som kaldes myelomatose.
Thalidomide Celgene is used with two other medicines called ‘melphalan’ and ‘prednisone’ to treat adults aged 65 years and over, with a type of cancer called multiple myeloma.
Thalidomide Celgene blev undersøgt i én hovedundersøgelse, hvori 447 patienter med multipelt myelom deltog.
Thalidomide Celgene was studied in one main study involving 447 patients with multiple myeloma.
Thalidomide Celgene er et lægemiddel, der indeholder det aktive stof thalidomid.
Thalidomide Celgene is a medicine containing the active substance thalidomide.
Thalidomide Celgene er hvide, hårde kapsler mærket ”Thalidomide Celgene 50 mg”.
Thalidomide Celgene are white hard capsules marked “Thalidomide Celgene 50 mg”.
Thalidomide Celgene i kombination med melphalan og prednison som førstevalgsbehandling af patienter med ubehandlet myelomatose på >65 år eller som er uegnede til højdosis kemoterapi.
Thalidomide Celgene in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy.
Thalidomide Celgene kan anvendes i maksimalt 12 behandlingsserier, hvor hver serie varer i seks uger.
Thalidomide Celgene can be used for a maximum of 12 treatment cycles, with each cycle lasting six weeks.
Thalidomide Celgene kan indtages sammen med eller uden mad (se punkt 3 ”Sådan skal du tage Thalidomide Celgene”).
Thalidomide Celgene can be taken with or without food (see section 3, “How to take Thalidomide Celgene”).
Thalidomide Celgene virker ved at hjælpe kroppens immunsystem og direkte angribe kræften.
Thalidomide Celgene works by helping the body’s immune system and directly attacking the cancer.
Thalidomide Celgenes Svangerskabsforebyggelsesprogram gennemgår advarslerne om thalidomids teratogene virkninger med det formål at vejlede omkring prævention før behandlingen påbegyndes, og indeholder retningslinjer mht. nødvendigheden af graviditetstests.
The Thalidomide Celgene Pregnancy Prevention Programme reinforces the warnings about the teratogenicity of thalidomide, provides advice on contraception before therapy is started and provides guidance on the need for pregnancy testing.
Thalidomids historie, baggrundsoplysninger om Thalidomide Celgene og den registrerede indikation
History of thalidomide, background on Thalidomide Celgene and its licensed indication
Thame, OX9 3EZ
Thame, OX9 3EZ United Kingdom
Thame, Oxon, OX9 3EZ, Det Forenede Kongerige
Thame, Oxon, OX9 3EZ, United Kingdom
The Barn, Manor Farm, Church Lane Chilcompton, Somerset BA3 4 HP Tel: +44-1761-417402
The Barn, Manor Farm, Church Lane Chilcompton, Somerset BA3 4 HP Tel:+44-1761-417402
The Clock House Station Approach
Eagle Laboratories Limited The Clock House
The Grange, 100 The High Street, London, N14 6BN, Storbritannien
The Grange, 100 The High Street, London, N14 6BN,
The holder of this marketing authorisation must inform the European Commission about the marketing plans for the medicinal product authorised by the decision.
The holder of this marketing authorisation must inform the European Commission about the marketing plans for the medicinal product authorised by this decision.
The Medicines Company UK Ltd 115L Milton Park, Abingdon Oxfordshire OX14 4SA STORBRITANNIEN
The Medicines Company UK Ltd 115L Milton Park, Abingdon Oxfordshire OX14 4SA UNITED KINGDOM
Thelin 100 mg filmovertrukne tabletter er gule til orange, kapselformede, filmovertrukne tabletter, , som er præget med T-100 på den ene side.
Thelin 100 mg film-coated tablets are yellow-to-orange, capsule-shaped tablets, marked with T-100 on one side.
Thelin bør ikke anvendes til børn under 18 år pga. manglende dokumentation for sikkerhed og effekt.
Thelin is not recommended for use in children and adolescents below 18 years due to a lack of data on safety and efficacy.
Thelins effekt på blødning
Effect of Thelin on bleeding
Thelins effekt som monoterapi er ikke blevet fastslået hos patienter med NYHA/WHO- funktionsklasse IV PAH.
The efficacy of Thelin as monotherapy has not been established in patients with NYHA/WHO functional class IV PAH.
Theophyllin (anvendes til at behandle vejrtrækningsproblemer) eller ikke-steroide antiinflammatoriske lægemidler (NSAIDer), som f.eks. fenbufen, acetylsalicylsyre (et stof, der findes i mange lægemidler, der anvendes til smertelindring og sænkning af feber samt til forebyggelse af blodpropper) eller ibuprofen.
Theophylline (used to treat breathing problems) or non-steroidal anti-inflammatory medicines (NSAIDs) such as fenbufen, acetylsalicylic acid (a substance present in many medicines used to relieve pain and lower fever, as well as to prevent blood clotting) or ibuprofen.
theophyllin (anvendes til at forbedre den bronkiale luftgennemstrømning),
theophylline (used to improve bronchial air flow);
Theophyllin (anvendes til behandling af astma)
Theophylline (used to treat asthma)
theophyllin (bruges i behandlingen af lungesygdomme såsom astma),
theophylline (used to treat respiratory diseases such as asthma),
theophyllin (bruges til behandling af astma) alle levende vacciner skal undgås, for eksempel vacciner mod mæslinger, fåresyge, influenza og gul feber.
theophylline (used to treat asthma) any vaccination with a live vaccine (must be avoided), such as measles, mumps, influenza or yellow fever vaccines.
theophyllin (medicin mod astma)
theophylline (used to treat asthma)
theophyllin mod astma
theophylline for asthma
theophyllin mod astma.
Theophylline for asthma
theophyllin til behandling af astma
theophylline, used to treat asthma
theophyllin – anvendes mod astma
theophylline - used for asthma
Theophyllin, fenbufen eller tilsvarende ikke-steroide antiinflammatoriske lægemidler
Theophylline, fenbufen or similar non-steroidal anti-inflammatory drugs
theophyllin, medicin til behandling af astma og andre lungesygdomme, må ikke anvendes i mindst 12 timer før du får Rapiscan, da det kan blokere Rapiscans virkning.
theophylline, a medicine used to treat asthma and other lung diseases, must not be used for at least 12 hours before you are given Rapiscan because it can block the effect of Rapiscan.
Theophyllin, som anvendes til behandling af svær astma og vejrtrækningsproblemer;
Theophylline, used to treat severe asthma and breathing problems;
theophyllin, som bruges til at behandle astma
theophylline, used to treat asthma
Theophyllin1 3 mg/kg hver 8. time 500 mg hver 12. time ↓ 43 % ↓ 32 % Øget dosering af theophyllin kan være nødvendig ved indgift sammen med ritonavir på grund af induktion af CYP1A2.
Theophylline1 3 mg/kg q8h 500 q12h ↓ 43% ↓ 32% An increased dose of theophyline may be required when co- administered with ritonavir, due to induction of CYP1A2.
Theophyllins metabolisering hæmmes af PegIntron hæmmende virkning på CYP1A2.
Metabolism of theophylline is suppressed by inhibitory action of the product (PegIntron) on CYP1A2.
Theophyllins, et CYP1A2-substrat, farmakokinetik blev ikke påvirket signifikant ved samtidig behandling med duloxetin (60 mg to gange daglig).
The pharmacokinetics of theophylline, a CYP1A2 substrate, were not significantly affected by co- administration with duloxetine (60 mg twice daily).
Therapeutische ervaring met clopidogrel bij patiënten met een nierfunctiestoornis is beperkt.
Therapeutic experience with clopidogrel is limited in patients with renal impairment.
Therapeutische indicaties
Therapeutic indications
There is no relevant use of docetaxel in the paediatric population in the indications breast cancer, non- small cell lung cancer, prostate cancer, gastric carcinoma and head and neck cancer, not including type II and III less differentiated nasopharyngeal carcinoma.
There is no relevant use of docetaxel in the paediatric population in the indications breast cancer, non-small cell lung cancer, prostate cancer, gastric carcinoma and head and neck cancer, not including type II and III less differentiated nasopharyngeal carcinoma.
Thiaziddiuretika (bruges til at nedsætte højt blodtryk),
thiazide diuretics (used to reduce high blood pressure),
Thiaziddiuretika kan øge serumkalciumniveauet på grund af nedsat udskillelse.
Calcium salts: Thiazide diuretics may increase serum calcium levels due to the decreased excretion.
thiaziddiuretika og saluretika, også kaldet vanddrivende tabletter (til behandling af højt blodtryk)
thiazide diuretics and saluretics also called water tablets (to treat high blood pressure)
Thiaziddiuretika, herunder hydrochlorthiazid, kan forstærke diazoxids hyperglykæmiske effekt.
Thiazide diuretics, including hydrochlorothiazide, may enhance the hyperglycaemic  effect of diazoxide.
Thiazider (til behandling af for højt blodtryk eller ved væskeophobning)
Thiazides (used to treat high blood pressure or excessive fluid retention)
Thiazider (til behandling af forhøjet blodtryk eller ved væskeophobning)
Thiazides (used to treat high blood pressure or excessive fluid retention)
Thiazider (vanddrivende tabletter)
Thiazides (diuretics or ‘water pills’)
Thiazider (vanddrivende tabletter)
Thiazides (diuretics or ‘water pills’).
Thiazider (vanddrivende tabletter).
Thiazides (diuretics or ‘water pills’).
thiazider eller andre diuretika (også kaldet vanddrivende tabletter)
thiazides or other diuretics (also called water tablets)
Thiazider kan reducere nyreudskillelsen af cytotoksiske stoffer (f.x cyclophosphamid, methotrexat) og forstærke deres myelosuppressive effekt.
Thiazides may reduce the renal excretion of cytotoxic medicinal products (e.g. cyclophosphamide, methotrexate) and potentiate their myelosuppressive effects.
Thiazider kan reducere nyreudskillelsen af cytotoksiske stoffer (f.x cyklofosfamid, methotrexat) og forstærke deres myelosuppresive effekt.
Thiazides may reduce the renal excretion of cytotoxic medicinal products (e.g. cyclophosphamide, methotrexate) and potentiate their myelosuppressive effects.
Thiazider kan sænke urin-calciumudskillelsen og forårsage intermitterende og let forhøjelse af serum- calcium uden kendte forstyrrelser af calciummetabolismen.
Thiazides may decrease urinary calcium excretion and cause an intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism.
Thiazider nedsætter calciumudskillelsen i urinen og kan forårsage en tilbagevendende og let stigning i serumcalcium uden tilstedeværelse af kendt forstyrrelse calciummetabolismen.
Thiazides reduce urinary calcium excretion and may cause an intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism.
Thiazider nedsætter calciumudskillelsen i urinen og kan forårsage en tilbagevendende og let stigning i serumcalcium uden tilstedeværelse af kendt forstyrrelse i calciummetabolismen.
Thiazides reduce urinary calcium excretion and may cause an intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism.
Thiazider nedsætter calciumudskillelsen i urinen og kan forårsage en tilbagevendende og let stigning i serumcalcium uden tilstedeværelse af kendte calciummetabolismesygdomme.
Thiazides reduce urinary calcium excretion and may cause an intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism.
Thiazider øger den antihypertensive virkning af andre antihypertensiva (fx guanethidin, methyldopa, betablokkere, vasodilatorer, calciumantagonister, ACE- hæmmere, angiotensin II-antagonister (ARBer) og direkte reninhæmmere [DRIer]).
Thiazides potentiate the antihypertensive action of other antihypertensive drugs (e.g. guanethidine, methyldopa, beta-blockers, vasodilators, calcium channel blockers, ACE inhibitors, ARBs and Direct Renin Inhibitors [DRIs]).
Thiazider, glukokortikoider, thyreoideahormoner og betasympatomimetika, væksthormon og danazol.
Thiazides, glucocorticoids, thyroid hormones and beta-sympathomimetics, growth hormone and danazol.
Thiazider, herunder hydrochlorthiazid, forstærker virkningen af perifert virkende muskelrelaksantia såsom curarederivater.
Thiazides, including hydrochlorothiazide, potentiate the action of curare derivatives.
Thiazider, herunder hydrochlorthiazid, kan forårsage forstyrrelser i væske- eller elektrolytbalancen (bl.a. hypokaliæmi, hyponatriæmi og hypochloræmisk alkalose).
Thiazides, including hydrochlorothiazide, can cause fluid or electrolyte imbalance (including hypokalaemia, hyponatraemia, and hypochloraemic alkalosis).
Thiaziders virkningsmåde er gennem hæmning af Na+Cl--symporteren, muligvis ved at konkurrere om C1--sitet, hvorved elektrolytreabsorptionsmekanismerne påvirkes: direkte virkning gennem øgning af natrium- og chloridudskillelsen i omtrent samme omfang, og indirekte virkning gennem den diuretiske effekt, der reducerer plasmavolumenet med deraf følgende stigninger i plasmareninaktivitet, aldosteronudskillelse og kaliumtab i urin samt en reduktion i serumkalium.
The mode of action of thiazides is through inhibition of the Na+Cl- symporter perhaps by competing for the Cl- site, thereby affecting electrolyte reabsorption mechanisms: directly increasing sodium and chloride excretion to an approximately equal extent, and indirectly, by this diuretic action, reducing plasma volume, with consequent increases in plasma renin activity, aldosterone secretion and urinary potassium loss, and a decrease in serum potassium.
Thiazolidindion
Thiazolidinedione
thiazolidindion, når thiazolidindion sammen med motion og diæt ikke giver tilstrækkelig glykæmisk kontrol hos patienter, hvor anvendelse af thiazolidindion anses for at være hensigtsmæssig.
a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate.
thiazolidindioner
thiazolidinediones
Thiazolidinedionerne virker primært ved at reducere insulinresistens og sulfonylurinstofferne virker primært ved at stimulere insulinfrigivelsen fra -cellerne i pankreas.
Thiazolidinediones act primarily by reducing insulin resistance and sulphonylureas act primarily by stimulating release of insulin from functioning pancreatic -cells.
Thiomersal
Thiomersal Sodium chloride
Thiomersal 0,05 milligram
Thiomersa 0.05 milligrams
Thiomersal 0,1 mg (*) svarende til titer før inaktivering (log10)
Thiomersal 0.1 mg (*)equivalent to titre prior to inactivation (log10)
Thiomersal 0,15 mg
Thiomersal 0.15 mg.
Thiomersal 0,2 mg.
Thiomersal 0.2 mg.
Thiomersal 0,21 mg
Thiomersal 0.21 mg
Thiomersal 50 mikrogram
Thiomersal 50 micrograms
Thiomersal Kaliumchlorid
Thiomersal Potassium chloride
Thiomersal maks.
Thiomersal max.
Thiomersal Natriumchlorid Kaliumchlorid
Thiomersal Sodium chloride Potassium chloride
Thiomersal Squalan Poloxamer 401
Thiomersal Squalane Poloxamer 401
Thiomersal, natriumchlorid, dinatriumhydrogenphosphat, kaliumdihydrogenphosphat, kaliumchlorid, vand til injektionsvæsker.
The other ingredients are: thiomersal, sodium chloride, disodium hydrogen phosphate, potassium dihydrogen phosphate, potassium chloride, water for injections
Thioridazin (til behandling af skizofreni) og imipramin (til behandling af depression).
Thioridazine (for the treatment of schizophrenia) and imipramine (for the treatment of depression).
thioridazin, et lægemiddel, der anvendes til behandling af skizofreni og psykose og som kan påvirke hjertet visse lægemidler mod depression, der kaldes monoaminoxidasehæmmere (MAO-hæmmere), f.eks. phenelzin og moclobemid).
thioridazine, a medicine used in the treatment of schizophrenia and psychosis, that may affect the heart, certain medicines for depression, called monoamine oxidase inhibitors (MAOIs- for example phenelzine and moklobemide).
Thiotepa er ikke undersøgt hos patienter med leverinsufficiens.
Thiotepa has not been studied in patients with hepatic impairment.
thoprim
Trimethoprim
thorax og
Hepatobiliary disorders
Thorinane 10.000 IE (100 mg) i 1,0 ml injektionsvæske, opløsning, i fyldt injektionssprøjte enoxaparinnatrium
Thorinane 10,000 IU (100 mg) in 1.0 mL solution for injection in pre-filled syringe enoxaparin sodium
Thorinane 10.000 IE (100 mg) i 1,0 ml injektionsvæske, opløsning, i fyldt sprøjte
Thorinane 10,000 IU (100 mg) in 1.0 mL solution for injection in pre-filled syringe
Thorinane 10.000 IE (100 mg) i1,0 ml
Thorinane 10,000 IU (100 mg) in 1.0 mL
Thorinane 2.000 IE (20 mg) i 0,2 ml injektionsvæske, opløsning, i fyldt injektionssprøjte enoxaparinnatrium
Thorinane 2,000 IU (20 mg) in 0.2 mL solution for injection in pre-filled syringe enoxaparin sodium
Thorinane 2.000 IE (20 mg) i 0,2 ml injektionsvæske, opløsning, i fyldt sprøjte
Thorinane 2,000 IU (20 mg) in 0.2 mL solution for injection in pre-filled syringe
Thorinane 2.000 IE (20 mg) i 0,2 ml.
Thorinane 2,000 IU (20 mg) in 0.2 mL
Thorinane 4.000 IE (40 mg) i 0,4 ml
Thorinane 4,000 IU (40 mg) in 0.4 mL
Thorinane 4.000 IE (40 mg) i 0,4 ml injektionsvæske, opløsning, i fyldt injektionssprøjte Enoxaparinnatrium
Thorinane 4,000 IU (40 mg) in 0.4 mL solution for injection in pre-filled syringe enoxaparin sodium
Thorinane 4.000 IE (40 mg) i 0,4 ml injektionsvæske, opløsning, i fyldt sprøjte
Thorinane 4,000 IU (40 mg) in 0.4 mL solution for injection in pre-filled syringe
Thorinane 6.000 IE (60 mg) i 0,6 ml
Thorinane 6,000 IU (60 mg) in 0.6 mL
Thorinane 6.000 IE (60 mg) i 0,6 ml injektionsvæske, opløsning, i fyldt injektionssprøjte enoxaparinnatrium
Thorinane 6,000 IU (60 mg) in 0.6 mL solution for injection in pre-filled syringe enoxaparin sodium
Thorinane 6.000 IE (60 mg) i 0,6 ml injektionsvæske, opløsning, i fyldt sprøjte
Thorinane 6,000 IU (60 mg) in 0.6 mL solution for injection in pre-filled syringe
Thorinane 8.000 IE (80 mg) i 0,8 ml
Thorinane 8,000 IU (80 mg) in 0.8 mL
Thorinane 8.000 IE (80 mg) i 0,8 ml injektionsvæske, opløsning, i fyldt injektionssprøjte enoxaparinnatrium
Thorinane 8,000 IU (80 mg) in 0.8 mL solution for injection in pre-filled syringe enoxaparin sodium
Thorinane 8.000 IE (80 mg) i 0,8 ml injektionsvæske, opløsning, i fyldt sprøjte
Thorinane 8,000 IU (80 mg) in 0.8 mL solution for injection in pre-filled syringe
Thorinane bruges hos voksne til at:
Thorinane is used in adults to:
Thorinane er et "biosimilært" lægemiddel.
Thorinane is a ‘biosimilar medicine’.
Thorinane er indiceret til voksne til:
Thorinane is indicated for adults for:
Thorinane indeholder natrium
Thorinane contains sodium
Thorinane må ikke administreres intramuskulært.
Thorinane must not be administered by the intramuscular route.
Thorinane må ikke blandes med andre injektion eller infusionsvæsker.
Thorinane should not be mixed with any other injections or infusions.
Thorinane må ikke blandes med andre injektioner eller infusioner.
Thorinane should not be mixed with any other injections or infusions.
Thorinane må ikke blandes med andre injektions- eller infusionsvæsker.
Thorinane should not be mixed with any other injections or infusions.
Thorinane påvirker ikke evnen til at føre motorkøretøj eller betjene maskiner.
Thorinane has no influence on the ability to drive and use machines.
Thrombo-
Thrombocytopenia
Thrombo- cytopeni, leukopeni, eosinofili
Thrombocytopenia, leucopenia, eosinophilia
Thrombocyto- peni, leukopeni, eosinofili
Thrombocytopenia, leucopenia, eosinophilia
Thrombocytopeni
thrombocytopaenia
Thrombocytopeni (G3/4: 1,6%);
Thrombocytopenia (G3/4: 1.6%);
Thrombocytopeni (G4: 0,2%)
Thrombocytopenia (G4: 0.2%)
Thrombocytopeni*, neutropeni*, anæmi*
Thrombocytopenia*, Neutropenia*, Anaemia
thrombocytopeni, eosinofili
thrombocytopenia, eosinophilia
Thrombocytopeni, lymphadenopati, lymphopeni
Thrombocytopaenia, lymphadenopathy, lymphopenia
Thrombocyttal skal være ≥ 70 x 109/l, og absolut neutrofiltal skal være ≥ 1,0 x 109/l
Platelet counts should be ≥ 70 x 109/l and the absolute neutrophils count should be ≥ 1.0 x 109/l
Thrombocyttal skal være ≥ 75.000 celler/μl hos patienter med infiltreret knoglemarv eller sekvestration af milten
Platelet counts should be ≥ 75,000 cells/μL in patients with bone marrow infiltration or splenic sequestration
Thromboflebit
Thrombophlebitis
ThromboGenics NV Gaston Geenslaan 1 B-3001 Leuven Belgien
ThromboGenics NV Gaston Geenslaan 1 B-3001 Leuven Belgium
thrombotisk thrombocytopenisk purpura
thrombotic thrombocytopenic purpura
thromycin, såsom azithromycin
against Mycobacterium avium
Thymanax 25 mg filmovertrukne tabletter
Thymanax 25 mg film-coated tablets
Thymanax 25 mg filmovertrukne tabletter Agomelatin
Thymanax 25 mg film-coated tablets Agomelatine